These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25980360)

  • 21. Essential fatty acids and related molecular and cellular mechanisms in multiple sclerosis: new looks at old concepts.
    Mayer M
    Folia Biol (Praha); 1999; 45(4):133-41. PubMed ID: 10732726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid proteomics in multiple sclerosis.
    Kroksveen AC; Opsahl JA; Guldbrandsen A; Myhr KM; Oveland E; Torkildsen Ø; Berven FS
    Biochim Biophys Acta; 2015 Jul; 1854(7):746-56. PubMed ID: 25526888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proteins and lipids in focal demyelinization in multiple sclerosis and chronic experimental allergic encephalomyelitis].
    Bukovský V; Mézesová V; Mézes V; Belej K; Moravcíková Y
    Bratisl Lek Listy; 1988 Oct; 89(10):725-32. PubMed ID: 3208158
    [No Abstract]   [Full Text] [Related]  

  • 25. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?
    Ibrahim SM; Gold R
    Curr Opin Neurol; 2005 Jun; 18(3):231-5. PubMed ID: 15891405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoenrichment microwave and magnetic proteomics for quantifying CD47 in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Mahesula S; Raphael I; Raghunathan R; Kalsaria K; Kotagiri V; Purkar AB; Anjanappa M; Shah D; Pericherla V; Jadhav YL; Gelfond JA; Forsthuber TG; Haskins WE
    Electrophoresis; 2012 Dec; 33(24):3820-9. PubMed ID: 23160929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.
    Hoppmann N; Graetz C; Paterka M; Poisa-Beiro L; Larochelle C; Hasan M; Lill CM; Zipp F; Siffrin V
    Brain; 2015 Apr; 138(Pt 4):902-17. PubMed ID: 25665584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.
    Kuerten S; Angelov DN
    Ann Anat; 2008; 190(1):1-15. PubMed ID: 18342137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S; Azari MF; Ozturk E; Papadopoulos R; Bernard CC
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):323-34. PubMed ID: 20448478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Models of multiple sclerosis: new insights into pathophysiology and repair.
    Lassmann H
    Curr Opin Neurol; 2008 Jun; 21(3):242-7. PubMed ID: 18451705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
    Han MH; Hwang SI; Roy DB; Lundgren DH; Price JV; Ousman SS; Fernald GH; Gerlitz B; Robinson WH; Baranzini SE; Grinnell BW; Raine CS; Sobel RA; Han DK; Steinman L
    Nature; 2008 Feb; 451(7182):1076-81. PubMed ID: 18278032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers.
    Sen MK; Almuslehi MSM; Shortland PJ; Mahns DA; Coorssen JR
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute neuroinflammation in Lewis rats - a model for acute multiple sclerosis relapses.
    Schneider C; Schuetz G; Zollner TM
    J Neuroimmunol; 2009 Aug; 213(1-2):84-90. PubMed ID: 19560215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
    Mc Guire C; Prinz M; Beyaert R; van Loo G
    Trends Mol Med; 2013 Oct; 19(10):604-13. PubMed ID: 24007818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.